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myocardial infarction (9.9% vs. 2.6%, p ¼0.015). The 6 and 12-month
MACE were also signiﬁcant higher in female patients (12.00% vs.
4.60%, p ¼0.035; 21.80% vs. 9.50%, p ¼0.022), mostly contributed by
higher 6-month target lesion revascularization (12.00% vs. 4.60%,
p ¼0.035). In-hospital mortality was 0.7% and 12-month accumulated
mortality for outpatients was 1.1% with no gender difference. Multi-
variate regression analysis showed that female gender was not the
independent risk factor for in-hospital MACE, but indeed, was for 6-
month (RR 9.013, p ¼0.003) and 12-month accumulated MACE (RR
7.806, p ¼0.005).
CONCLUSIONS Rotational atherectomy is safe, feasible and facilitates
stent implantation with high procedural success for both genders.
However, female patients had worse outcome for short and long-term
follow-up, therefore should be treated more carefully and observed
more intensively, especially during the ﬁrst 6 months after the pro-
cedure.
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Correlation analysis of reperfusion induced hypotension during primary
percutaneous coronary intervention after acute myocardial infarction
Yongbin LI, Zhuhua Yao
Tianjin Union Medicine Center
OBJECTIVES This study aims to investigate the predictors of reper-
fusion induced hypotension (RIH) during the surgery of primary
percutaneous coronary intervention (PCI) after the acute ST-segment
elevated myocardial infarction (STEMI), as well as the impact of RIH
on the prognosis.
METHODS A retrospective analysis was performed towards the 204
STEMI patients who were performed the primary PCI in our hospital
from January 2009 to June 2013, the patients were divided into the
RIH group and the non-RIH group, the clinical data of the 2 groups
were collected and compared, the Logistic regression equation was
performed to analyze the RIH predictors; the 12-month follow-up was
performed to compare the differences in the major adverse cardiac
events (MACEs) between the two groups.
RESULTS The intergroup comparison showed that the infarct-related
artery (IRA) of the RIH group was mainly the right coronary artery
(RCA) (75.0% to 27.7%, P¼0.000), the reperfusion time was shorter
(4.7  0.8 to 6.8  2.8, P ¼0.040); the Logistic regression analysis
showed that IRA (OR: 5.956, 95% CI: 1.298-10.878, P ¼0.015) and
reperfusion time (OR: 4.262, 95% CI: 0.110-0.944, P ¼0.039) were the
predictors of RIH. During the hospitalization and 12-month follow-up,
there was no signiﬁcant difference in MACEs between the 2 groups
(P¼0.608 and 0.499, respectively).
CONCLUSIONS The RCA lesions and short reperfusion time were the
predictors of RIH; there was no signiﬁcant increase of MACEs during
the 12-month follow-up towards the RIH patients.
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Early and Long-Term Outcomes After Percutaneous Coronary
Intervention of Unprotected Left Main Coronary Disease With
Drug-Eluting Stents in Patients With Non-ST-Elevation Acute Coronary
Syndrome
Lianqun Cui
Provincial Hospital afﬁliated to Shandong University
OBJECTIVES Patients presenting with non-ST-elevation acute
coronary syndrome (NSTE-ACS) and unprotected left main coronary
dis-ease (ULMCD) are among the highest risk patients but current
consen-sus guidelines do not address the optimal timing and mode of
revascularization for these individuals.
METHODS In this single-centre registry, we evaluated the clinical out-
comes of 151 consecutive patients with NSTE-ACS and ULMCD who
underwent percutaneous coronary intervention with drug-eluting
stents from 2005 to 2009.
RESULTS Overall in-hospital major adverse cardiac event (MACE)
rate was 5.3%, mortality rate was 0.7%. At 30 months 15 months, 30
patients (19.9%) experienced MACE. The 4-year cumulative survival
rate of no MACE was 73.2% and cumulative survival rate was 90.6%.
Left ventricular ejection fraction (hazard ratio [HR] 0.947; 95% con-
ﬁdence interval [CI], 0.898-0.998; P ¼0.043) and SYNTAX [SYNergy
between percutaneous coronary intervention with TAXus and cardiac
surgery] score 33 (HR 1.28; 95% CI, 1.025-1.433; P ¼0.029) wereassociated with MACE, while only left ventricular ejection fraction
(HR 0.82; 95% CI, 0.69-0.973; P ¼0.023) was associated with
mortality.
CONCLUSIONS Our study demonstrates the feasibility of PCI with
DES tothe very high-risk subgroup of patients with NSTE-ACS
andULMCD. The early and long-term outcomes were acceptable and
compared favorably with historical surgical data in patients with
ULMCD and ACS. SYNTAX score 33 predicts MACE in patients with
NSTE-ACS and ULMCD who underwent PCI. The ideal revasculariza-
tion strategy for patients withNSTE-ACS and ULMCD is unknown.
Randomized, controlled trials are needed to further elucidate the
optimal treatment strategy.GW26-e4712
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Coronary Angiography: A Non-inferiority Trial
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OBJECTIVES Dual-axis rotational coronary angiography (DARCA) re-
quires a longer coronary injection compared to standard coronary
angiography (SA). The risk of complications from the contrast agent is
increased with the use of DARCA. Previous studies revealed promising
results, but the number of patients included did not provide sufﬁcient
statistical power to allow a valid comparison of DARCA with SA. This
study was to evaluate the safety and efﬁcacy of DARCA in comparison
to the SA.
METHODS We undertook a single centre non-inferiority randomized
controlled study. 576 patients aged 18 years or older with a clinical
indication for diagnostic coronary angiography to evaluate possible
coronary artery disease were randomized to either the SA group
(n¼288) or DARCA group (n¼288). The primary endpoint was a com-
posite of discomfort (the sensation of warmth or pain) and adverse
events (arrhythmias, hemodynamic instability, chest pain lasting
more than one minute and any untoward event which jeopardizes the
patient’s life or prolongs the planned hospital stay), as well as adverse
events alone, during or immediately after coronary angiography.
Analysis was by per-protocol.
RESULTS We analyzed 274 patients in the DARCA group and 278 in
the SA group per protocol. The primary end point occurred in 82
(29.9%) patients assigned to DARCA as compared with 64 (23.0%)
patients assigned to SA (difference: 0.069 [95% CI: 0.005 to 0.142],
P¼0.385 for non-inferiority). Adverse events alone occurred in 35
(12.8%) patients in the DARCA group as compared with 40 (14.4%)
patients in the SA group (difference: -0.016 [95% CI: 0.074 to 0.042],
P<0.001 for non-inferiority). Compared to the SA group, a higher rate
of discomfort was observed in the DARCA group (19.3% vs. 11.2%,
adjusted relative risk: 1.78 [95% CI: 1.19 to 2.66], P¼0.005) due to the
higher rate of warmth (15.3% vs. 9.7%, adjusted relative risk: 1.63 [95%
CI: 1.04 to 2.54], P¼0.033), rather than chest pain (4.4% vs. 2.9%,
adjusted relative risk: 1.57 [95% CI: 0.66 to 3.73], P¼0.304).
CONCLUSIONS DARCA is as safe as SA in the diagnosis of coronary
artery disease with respect to adverse events, but experiences more
warmth.
This study is registered with ClinicalTrials.gov, number
NCT01625533.GW26-e5451
Real world experience of Primary PCI in 1000 STEMI patients in Indian
scenario at a tertiary care center
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OBJECTIVES India has highest burden of coronary artery disease in
the world. It also has a higher rate of ST-segment elevation myocardial
infarction than developed countries. Primary percutaneous coronary
intervention is the effective treatment, yet little is known about its
feasibility and outcomes in India. We aimed to study the outcomes of
primary percutaneous coronary intervention in Indian scenario.
METHODS We did a prospective observational study of one thousand
consecutive ST-elevation myocardial infarction patients, treated with
primary percutaneous coronary intervention from December 2010 to
